Combined analysis evaluates the performance of CINSARC and Sarculator models in predicting overall and disease-free survival in primary retroperitoneal sarcoma patients.
ROC curves: Time-dependent ROC curves at 5 and 10 years for OS (A and B) and DFS (C and D) in the pooled cohort, comparing different prognostic models. The Sarculator model (black), Sarculator + CINSARC (yellow), and CINSARC alone (blue) are shown. The diagonal reference line represents a nondiscriminatory model. AUC values quantify the discriminative performance of each model.
No takes yet. Share an insight, caveat, or question.
Callegaro et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: